Casein kinase 1 epsilon expression predicts poorer prognosis in low T-stage oral cancer patients

International Journal of Molecular Sciences

Volumn 15, Issue 2, 2014, Pages 2876-2891

  Lin, Shu Hui ^a,b,c   Lin, Yueh Min ^b,c   Yeh, Chung Min ^b,c   Chen, Chih Jung ^a,b,c   Chen, Mei Wen ^b,d   Hung, Hsiao Fang ^c   Yeh, Kun Tu ^a,b   Yang, Shun Fa ^a,e  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c JEN TEH JUNIOR COLLEGE OF MEDICINE   (Taiwan)

^d CHIENKUO TECHNOLOGY UNIVERSITY   (Taiwan)

^e CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Casein kinase 1 epsilon (CK1 ); Oral cancer; Overall survival

Indexed keywords

CASEIN KINASE IEPSILON;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER STAGING; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; OVERALL SURVIVAL; PROTEIN EXPRESSION; SQUAMOUS EPITHELIUM; TISSUE MICROARRAY; VERY ELDERLY; WESTERN BLOTTING; CARCINOMA, SQUAMOUS CELL; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; MOUTH NEOPLASMS; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASEIN KINASE IEPSILON; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES;

EID: 84894255905     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15022876     Document Type: Article

References (31)

1. Cancer Registration System Annual Report; Bureau of Health Promotion, Department of Health: New Taipei City, Taiwan, 2010.
2. Leite, I.C.; Koifman, S. Survival analysis in a sample of oral cancer patients at a reference hospital in Rio de Janeiro, Brazil. Oral Oncol. 1998, 34, 347-352.
3. Lo, W.L.; Kao, S.Y.; Chi, L.Y.; Wong, Y.K.; Chang, R.C. Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: Factors affecting survival. J. Oral Maxillofac. Surg. 2003, 61, 751-758.
4. Argiris, A.; Karamouzis, M.V.; Raben, D.; Ferris, R.L. Head and neck cancer. Lancet 2008, 371, 1695-1709.
5. Chiesa, F.; Mauri, S.; Tradati, N.; Calabrese, L.; Giugliano, G.; Ansarin, M.; Andrle, J.; Zurrida, S.; Orecchia, R.; Scully, C. Surfing prognostic factors in head and neck cancer at the millennium. Oral Oncol. 1999, 35, 590-596.
6. Helliwell, T.R. Molecular markers of metastasis in squamous carcinomas. J. Pathol. 2001, 194, 289-293.
7. Lopes, M.A.; Nikitakis, N.G.; Reynolds, M.A.; Ord, R.A.; Sauk, J., Jr. Biomarkers predictive of lymph node metastases in oral squamous cell carcinoma. J. Oral Maxillofac. Surg. 2002, 60, 142-147.
8. Rodrigo, J.P.; Suarez, C.; Ferlito, A.; Devaney, K.O.; Petruzzelli, G.J.; Rinaldo, A. Potential molecular prognostic markers for lymph node metastasis in head and neck squamous cell carcinoma. Acta Otolaryngol. 2003, 123, 100-105.
9. Lallemant, B.; Evrard, A.; Combescure, C.; Chapuis, H.; Chambon, G.; Raynal, C.; Reynaud, C.; Sabra, O.; Joubert, D.; Hollande, F.; et al. Clinical relevance of nine transcriptional molecular markers for the diagnosis of head and neck squamous cell carcinoma in tissue and saliva rinse. BMC Cancer 2009, 9, 370:1-370:10.
10. Shah, N.G.; Trivedi, T.I.; Tankshali, R.A.; Goswami, J.V.; Jetly, D.H.; Shukla, S.N.; Shah, P.M.; Verma, R.J. Prognostic significance of molecular markers in oral squamous cell carcinoma: A multivariate analysis. Head Neck 2009, 31, 1544-1556.
11. Gross, S.D.; Anderson, R.A. Casein kinase I: Spatial organization and positioning of a multifunctional protein kinase family. Cell Signal. 1998, 10, 699-711.
12. Knippschild, U.; Gocht, A.; Wolff, S.; Huber, N.; Löhler, J.; Stöter, M. The casein kinase I family: Participation in multiple cellular processes in eukaryotes. Cell Signal. 2005, 17, 675-689.
13. Price, M.A. CKI: There's more than one: Casein kinase I family members in Wnt and Hedgehog signaling. Genes Dev. 2006, 20, 399-410.
14. Brockschmidt, C.; Hirner, H.; Huber, N.; Eismann, T.; Hillenbrand, A.; Giamas, G.; Radunsky, B.; Ammerpohl, O.; Bohm, B.; Henne-Bruns, D.; et al. Anti-apoptotic and growth-stimulatory functions of CKI delta and epsilon in ductal adenocarcinoma of the pancreas are inhibited by IC261 in vitro and in vivo. Gut 2008, 57, 799-806.
15. Frierson, H.F., Jr.; El-Naggar, A.K.; Welsh, J.B.; Sapinoso, L.M.; Su, A.I.; Cheng, J.; Saku, T.; Moskaluk, C.A.; Hampton, G.M. Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am. J. Pathol. 2002, 161, 1315-1323.
16. Peters, J.M.; McKay, R.M.; McKay, J.P.; Graff, J.M. Casein kinase I transduces Wnt signals. Nature 1999, 401, 345-350.
17. Polakis, P. The many ways of Wnt in cancer. Curr. Opin. Genet. Dev. 2007, 17, 45-51.
18. Rodriguez, N.; Yang, J.; Hasselblatt, K.; Liu, S.; Zhou, Y.; Rauh-Hain, J.A.; Ng, S.K.; Choi, P.W.; Fong, W.P.; Agar, N.Y.; et al. Casein kinase I epsilon interacts with mitochondrial proteins for the growth and survival of human ovarian cancer cells. EMBO Mol. Med. 2012, 4, 952-963.
19. Modak, C.; Chai, J. Potential of casein kinase I in digestive cancer screening. World J. Gastrointest. Oncol. 2009, 1, 26-33.
20. Yang, Y.H.; Chen, C.H.; Chang, J.S.; Lin, C.C.; Cheng, T.C.; Shieh, T.Y. Incidence rates of oral cancer and oral pre-cancerous lesions in a 6-year follow-up study of a Taiwanese aboriginal community. J. Oral Pathol. Med. 2005, 34, 596-601.
21. Fedele, S. Diagnostic aids in the screening of oral cancer. Head Neck Oncol. 2009, 1, 5:1-5:6.
22. Fuja, T.J.; Lin, F.; Osann, K.E.; Bryant, P.J. Somatic mutations and altered expression of the candidate tumor suppressors CSNK1; DLG1; and EDD/hHYDin mammary ductal carcinoma. Cancer Res. 2004, 64, 942-951.
23. Hsu, C.M.; Lin, S.F.; Lu, C.T.; Lin, P.M.; Yang, M.Y. Altered expression of circadian clock genes in head and neck squamous cell carcinoma. Tumour Biol. 2012, 33, 149-155.
24. Flajolet, M.; He, G.; Heiman, M.; Lin, A.; Nairn, A.C.; Greengard, P. Regulation of Alzheimer's disease amyloid-beta formation by casein kinase I. Proc. Natl. Acad. Sci. USA 2007, 104, 4159-4164.
25. Umar, S.; Wang, Y.; Morris, A.P.; Sellin, J.H. Dual alterations in casein kinase I-epsilon and GSK-3beta modulate beta-catenin stability in hyperproliferating colonic epithelia. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292, G599-G607.
26. Tsai, I.C.; Amack, J.D.; Gao, Z.H.; Band, V.; Yost, H.J.; Virshup D.M. A Wnt-CKIvarepsilon-Rap1 pathway regulates gastrulation by modulating SIPA1L1: A Rap GTPase activating protein. Dev. Cell 2007, 12, 335-347.
27. Cegielska, A.; Gietzen, K.F.; Rivers, A.; Virshup, D.M. Autoinhibition of casein kinase I epsilon (CKI epsilon) is relieved by protein phosphatases and limited proteolysis. J. Biol. Chem. 1998, 273, 1357-1364.
28. Michl, P.; Downward, J. Mechanisms of disease: PI3K/AKT signaling in gastrointestinal cancers. Z. Gastroenterol. 2005, 43, 1133-1139.
29. Foldynová-Trantírková, S.; Sekyrová, P.; Tmejová, K.; Brumovská, E.; Bernatík, O.; Blankenfeldt, W. Breast cancer-specific mutations in CK1e inhibit Wnt/β-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration. Breast Cancer Res. 2010, 12, R30:1-R30:14.
30. Kim, S.Y.; Dunn, I.F.; Firestein, R.; Gupta, P.; Wardwell, L.; Repich, K.; Schinzel, A.C.; Wittner, B.; Silver, S.J.; Root, D.E.; et al. CK1e is required for breast cancers dependent on β-catenin activity. PLoS One 2010, 5, e8979.
31. Lin, C.W.; Chen, P.N.; Chen, M.K.; Yang, W.E.; Tang, C.H.; Yang, S.F.; Hsieh, Y.S. Kaempferol reduces matrix metalloproteinase-2 expression by down-regulating ERK1/2 and the activator protein-1 signaling pathways in oral cancer cells. PLoS One 2013, 8, e80883.